METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Clinical trials for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Indianized mediterranean diet takes on fatty liver in children
Disease control Recruiting nowThis study compares an Indianized version of the Mediterranean diet to a standard low-fat diet for reducing liver fat in overweight children and teens aged 8-18 with a liver condition called MASLD. The goal is to see which diet helps more kids achieve normal liver fat levels afte…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Disease control
Last updated May 26, 2026 08:42 UTC
-
Period-Pausing drug may fight fatty liver in endometriosis patients
Disease control Recruiting nowThis study looks at whether a medication called goserelin acetate, which temporarily stops menstruation (like a short-term menopause), can reduce fat buildup in the liver of women with endometriosis. The researchers will measure liver fat and stiffness using ultrasound in 62 wome…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE4 • Sponsor: Aristotle University Of Thessaloniki • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
Could a simple stomach tuck reverse fatty liver disease?
Disease control Recruiting nowThis study tests whether a minimally invasive procedure called endoscopic sleeve gastroplasty (ESG), which reduces stomach size by about 70%, can help people with obesity and a serious liver condition called MASH. Participants will be randomly assigned to receive either ESG plus …
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Pichamol Jirapinyo, MD, MPH • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
Can two diabetes drugs stop fatty liver from turning deadly?
Disease control Recruiting nowThis study tests two medications, retatrutide and tirzepatide, to see if they can prevent major liver complications like cirrhosis or liver failure in adults with a high-risk form of fatty liver disease (MASLD). About 4,500 participants will be randomly assigned to receive one of…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
New drug trial targets fatty liver disease – could it reduce liver fat?
Disease control Recruiting nowThis study tests an experimental drug called ALN-CIDEB in adults with fatty liver disease (MASLD or MASH). The goal is to check safety and how well the drug reduces liver fat. About 132 participants will receive either the drug or a placebo. The study is currently recruiting.
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 08:31 UTC
-
Could a gut antibiotic shrink fatty liver? new trial launches
Disease control Recruiting nowThis early-stage study tests whether the antibiotic rifaximin-α can reduce liver fat in people with metabolic fatty liver disease (MASLD). About 60 adults will take either the drug or just follow lifestyle advice for 24 weeks, then be monitored for another 24 weeks. The goal is t…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
Gut bacteria capsule could tame fatty liver, early trial hopes
Disease control Recruiting nowThis early-stage study tests a probiotic capsule made from a pasteurized gut bacterium (Akkermansia muciniphila) in 40 adults with metabolic fatty liver disease (MASLD). The goal is to see if it safely reduces liver fat and scarring. Participants take different doses of the capsu…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: PHASE1 • Sponsor: Leeuwenhoek Laboratories Co. Ltd. • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
New ultrasound test could replace MRI for fatty liver diagnosis
Diagnosis Recruiting nowThis study is testing a new ultrasound-based method called DeepUSFF to measure liver fat in people with fatty liver disease. Researchers will compare the ultrasound results to MRI scans, which are the current gold standard. The goal is to see if the simpler, cheaper ultrasound ca…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Diagnosis
Last updated May 26, 2026 08:29 UTC
-
AI chatbot aims to curb alcohol use in liver disease patients
Symptom relief Recruiting nowThis study tests whether a chatbot powered by large language models can help people with metabolic alcohol-related liver disease (MetALD) reduce their alcohol intake. About 50 adults in Hong Kong will use the chatbot for counseling. The main goals are to see if the approach is fe…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated May 26, 2026 08:33 UTC
-
Tiny cell talk may hold key to fatty liver disease
Knowledge-focused Recruiting nowThis study looks at 20 adults having weight-loss surgery to understand how a breakdown in communication between parts of liver cells might lead to MASH, a serious liver condition. Researchers will take small liver samples during surgery and blood tests before and after to track t…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 26, 2026 08:53 UTC
-
Fatty liver may boost kidney stone risk, new study investigates
Knowledge-focused Recruiting nowThis study looks at how much oxalate the body naturally produces in people with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), a type of fatty liver. Researchers will measure oxalate levels in urine after participants eat a special low-oxalate diet. The goal is…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated May 26, 2026 08:52 UTC
-
Computer alert could spot hidden liver damage in primary care
Knowledge-focused Recruiting nowThis study looks at whether a special alert in the electronic health record can help primary care doctors identify patients with MASLD who may have advanced liver scarring. About 225 adults with MASLD will take part. The goal is to see if the alert leads to more testing and earli…
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Knowledge-focused
Last updated May 26, 2026 08:34 UTC
-
New study aims to uncover hidden liver risks in diabetes patients
Knowledge-focused Recruiting nowThis study will follow 1000 adults in Hong Kong who have both type 2 diabetes and a common liver condition called MASLD (fatty liver disease). Researchers want to understand how these two conditions interact over time and what factors predict serious outcomes like liver scarring …
Matched conditions: METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC